Trials / Unknown
UnknownNCT01977378
A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder
A Double-Blind,Venlafaxine-Controlled Study of Efficacy and Safety of Sustained-Release Desvenlafaxine Hydrochloride in the Treatment of Major Depressive Disorder
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, 10-week study to evaluate the efficacy and safety of Sustained-Release Desvenlafaxine Hydrochloride versus Sustained-Release venlafaxine Hydrochloride in adult with major depressive disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sustained-Release Desvenlafaxine Hydrochloride | |
| DRUG | Sustained-Release Venlafaxine Hydrochloride |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-09-01
- First posted
- 2013-11-06
- Last updated
- 2013-11-06
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01977378. Inclusion in this directory is not an endorsement.